Board of Directors

2020-06-02T09:56:56+00:00

Jeroen Bakker

PhD, Principal at Novo Holdings
 
Has a broad background in VC, Corporate VC, and biotech consultancy.
2020-06-02T09:46:11+00:00

Thomas Needham

MBA, Director at Broadview Ventures Inc

25 years of experience in VC investments, business development, corporate strategy, and executive management.
2019-05-20T08:25:57+00:00

Prof. Jens Juul Holst

MD, DMSC, Co-founder

Discoverer of GLP-1, with over 1200 publications. The most cited living physiologist between 1996-2006.

2020-06-02T09:27:33+00:00

Philip Just Larsen

MD, PhD

SVP and Global Head of research at Bayer Pharmaceuticals with 20 years of experience leading research divisions within the pharmaceutical industry.

2019-05-20T07:56:40+00:00

Anker Lundemose

MD, PhD, DMSc

CEO of Mission Therapeutics with a track record in biotech M&A, BD&L and VC investment.
.

2019-05-20T07:56:25+00:00

Kirsten Drejer

M.Sc., PhD

Co-founder and former CEO of Symphogen with a long history of leadership positions at Novo Nordisk.

2019-05-20T08:27:16+00:00

Emmanuelle Coutanceau

PhD, Partner at Novo Holdings

Partner at Novo Holdings with over 10 years of experience in VC investment.
.

Go to Top